By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Caladrius Biosciences (Formerly Known As NeoStem, Inc.)  

420 Lexington Ave, Suite 350

New York  New York  10170  U.S.A.
Phone: 212-584-4180 Fax: 425-696-4651




Company News
Caladrius Biosciences (CLBS) Subsidiary, PCT, Announces Five-Year Strategic Manufacturing Services Agreement With Adaptimmune 9/19/2016 8:47:11 AM
Caladrius Biosciences (CLBS) Enters Into Agreements To Raise $25 Million In Common Equity Priced At Market Without Warrants 9/15/2016 8:34:23 AM
Caladrius Biosciences (CLBS) To Present At Upcoming September Conferences 9/8/2016 8:14:19 AM
Caladrius Biosciences (CLBS) Reports 2016 Second Quarter Financial Results 8/10/2016 11:06:52 AM
Caladrius Biosciences (CLBS) To Host 2016 Second Quarter Financial Results Conference Call On August 9 At 5:00 Pm Eastern Time 8/2/2016 8:22:41 AM
Caladrius Biosciences (CLBS) Receives FDA Fast Track Designation For CLBS03 To Treat Recent Onset Type 1 Diabetes 7/28/2016 10:18:05 AM
Caladrius Biosciences (CLBS) Announces 1-For-10 Reverse Split 7/27/2016 8:16:28 AM
Caladrius Biosciences (CLBS) To Present At Upcoming July Conferences 7/7/2016 8:46:23 AM
The Alliance for Regenerative Medicine (ARM) Welcomes New Chairman, Bob Preti, Ph.D., President Of PCT And SVP Of Caladrius Biosciences (CLBS) 6/28/2016 2:35:04 PM
Caladrius Biosciences (CLBS) Licenses Key Technology and Subleases Irvine Facility to AiVita Biomedical 5/26/2016 5:57:14 AM